Biogen: completes acquisition of Reata Pharmaceuticals

(CercleFinance.com) - Biogen announces that it has completed the acquisition of Reata Pharmaceuticals, a company that develops therapies that regulate cellular metabolism and inflammation in severe neurological diseases.


Biogen anticipates significant synergies with its existing rare disease portfolio and expects to update its financial guidance for 2023 when it publishes its Q3 results.


Copyright (c) 2023 CercleFinance.com. All rights reserved.